The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

German retail sales rose in 2024, but growth should be more modest this year due to the high level of uncertainty, according ...

Q4 2024 Management View CEO Rob Michael highlighted AbbVie's strong Q4 2024 performance, which exceeded initial guidance with ...

Wall Street analysts forecast the company will manage a 4.3% revenue increase in 2025, accompanied by a 1.5% rebound in EPS.

Read about RTX's fourth-quarter financial performance, including 9 percent sales growth and $218 billion in total backlog.

Two years after AbbVie’s loss of market exclusivity for Humira, those “How it Started and How it’s Going” memes are looking ...

Q4 2024 Management View CEO Donald Macpherson emphasized the company's strong financial performance in 2024, highlighting ...

CEO Vas Narasimhan highlighted Novartis' strong performance in Q4 2024, with sales increasing 16% and core operating income rising 29% in constant currency. For the full year, the company achieved a ...

Read about Lockheed Martin's financial results for 2024 and learn more about the business performances that contributed to it ...

Kimberly-Clark Corporation traded lower in premarket action on Tuesday after the household products company posted a mixed Q4 ...

Again the sticky point for Tesla's quarterly revenue was lower average selling price for its EVs, the company said. Despite being a miss relative to expectations, the $25.7 billion revenue was a 2% ...